MARTIN MATZUK, PHD
Medical Practice at Taub Loop, Houston, TX
License number
Texas J4911
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
Address
Address
1504 Taub Loop, Houston, TX 77030
Phone
(713) 873-3200
(713) 873-3214 (Fax)
(713) 873-3214 (Fax)
Personal information
See more information about MARTIN MATZUK at radaris.comName
Address
Phone
2926 Russett Pl W, Pearland, TX 77584
Houston, TX
3807 Durness Way, Houston, TX 77025
1 Baylor Plz, Houston, TX 77030
2926 Russett Pl, Pearland, TX 77584
Organization information
See more information about MARTIN MATZUK at bizstanding.comMartin Matzuk MD,PHD
1 Baylor Plz, Houston, TX 77030
Site:
Phone:
(713) 798-6451 (Phone)
Description:
There are 28 doctors at this site. Surgery is not performed at this site.
Martin Matthew Matzuk
Professional information
Martin Matthew Matzuk, Houston TX
Specialties:
Pathology, Clinical Pathology, Clinical Pathology/Laboratory Medicine, Anatomic Pathology & Clinical Pathology
Work:
Baylor College of Medicine
1 Baylor Plz, Houston, TX 77030
1 Baylor Plz, Houston, TX 77030
Education:
Washington University at St. Louis (1989)
Dr. Martin Matzuk, Houston TX - MD (Doctor of Medicine)
Specialties:
Clinical Pathology
Address:
Baylor College Of Med Pathology
1 Baylor Plz SUITE 286A, Houston 77030
(713) 798-4661 (Phone)
1 Baylor Plz SUITE 286A, Houston 77030
(713) 798-4661 (Phone)
Certifications:
Clinical Pathology, 2006
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Baylor College Of Med Pathology
1 Baylor Plz SUITE 286A, Houston 77030
Ben Taub General Hospital
1504 Taub Loop, Houston 77030
1 Baylor Plz SUITE 286A, Houston 77030
Ben Taub General Hospital
1504 Taub Loop, Houston 77030
Education:
Medical School
Washington Center / School of Medicine
Graduated: 1989
Baylor College Of Med
Washington Center / School of Medicine
Graduated: 1989
Baylor College Of Med
Martin Matzuk, Houston TX
Specialties:
Pathologist
Address:
1504 Taub Loop, Houston, TX 77030
Martin Matzuk
Location:
Houston, Texas Area
Industry:
Medical Practice
Ovary-Specific Genes And Proteins
US Patent:
7335737, Feb 26, 2008
Filed:
Nov 9, 2005
Appl. No.:
11/270717
Inventors:
Martin M. Matzuk - Houston TX, US
Pei Wang - Houston TX, US
Pei Wang - Houston TX, US
Assignee:
Baylor College of Medicine - Houston TX
International Classification:
C07K 14/00, A61K 38/00
US Classification:
530350, 4241851
Abstract:
Ovary specific proteins O1 180, O1 184 and O1 236, polynucleotides encoding them, antibodies which are immunoreactive with them and vectors and host cells containing O1 180, O1 184 or O1 236 are provided. Also provided are methods for detecting cell proliferative or degenerative disorders of ovarian origin and which are associated with O1 180, O1 184 or O1 236. Further provided are methods for the evaluation of potential contraceptives using the proteins of the invention, as well as methods for the screening for genetic mutations in signaling pathways that are associated with some forms of human infertility or gynecological cancers, also using the proteins/mRNAs/genes of the invention. The proteins/mRNAs/genes of the invention may also be used as markers for identifying primary and metastatic neoplasms of ovarian origin and as indicators of developmental anomalies in prenatal screening procedures. Furthermore, assays of the proteins/mRNAs/genes of the invention can be used in diagnostic assays for detecting forms of infertility and other diseases, including germ cell tumors and polycystic ovary syndrome. The proteins of the invention may be useful targets for in vitro fertilization procedures or in enhancing the number of eggs that can be retrieved from the human donor, e. g.
Ovary-Specific Genes And Proteins
US Patent:
2008029, Nov 27, 2008
Filed:
Dec 14, 2007
Appl. No.:
11/956641
Inventors:
Martin M. Matzuk - Houston TX, US
Pei Wang - Houston TX, US
Pei Wang - Houston TX, US
International Classification:
C12N 11/00, C07K 16/18
US Classification:
435174, 5303879, 5303913
Abstract:
Ovary specific proteins O1 180, O1 184 and O1 236, polynucleotides encoding them, antibodies which are immunoreactive with them and vectors and host cells containing O1 180, O1 184 or O1 236 are provided. Also provided are methods for detecting cell proliferative or degenerative disorders of ovarian origin and which are associated with O1 180, O1 184 or O1 236. Further provided are methods for the evaluation of potential contraceptives using the proteins of the invention, as well as methods for the screening for genetic mutations in signaling pathways that are associated with some forms of human infertility or gynecological cancers, also using the proteins/mRNAs/genes of the invention. The proteins/mRNAs/genes of the invention may also be used as markers for identifying primary and metastatic neoplasms of ovarian origin and as indicators of developmental anomalies in prenatal screening procedures. Furthermore, assays of the proteins/mRNAs/genes of the invention can be used in diagnostic assays for detecting forms of infertility and other diseases, including germ cell tumors and polycystic ovary syndrome. The proteins of the invention may be useful targets for in vitro fertilization procedures or in enhancing the number of eggs that can be retrieved from the human donor, e.g., in enhancing the success rate.
Tex14 Compositions And Modulators Thereof To Alter Intercellular Bridge Development And Function
US Patent:
2006022, Oct 5, 2006
Filed:
Mar 30, 2006
Appl. No.:
11/393642
Inventors:
Martin Matzuk - Houston TX, US
Michael Greenbaum - Houston TX, US
Aleksandar Rajkovic - Houston TX, US
Michael Greenbaum - Houston TX, US
Aleksandar Rajkovic - Houston TX, US
Assignee:
BAYLOR COLLEGE OF MEDICINE - Houston TX
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
The present invention is related to TEX14 and germ cell intercellular bridges and compositions thereof that can be used to inhibit and/or decrease the activity and/or expression of TEX14 and/or disrupt the formation, function, and/or integrity of the intercellular bridges, including localization of key components to the intercellular bridge, for example. In particular aspects, the methods and compositions are employed for fertility and infertility applications.
Microrna Mirna-31 As A Therapeutic Approach For The Treatment Of Cancer
US Patent:
2013006, Mar 14, 2013
Filed:
Oct 14, 2010
Appl. No.:
13/501806
Inventors:
Martin M. Matzuk - Houston TX, US
Chad Creighton - Houston TX, US
Zhifeng Yu - Houston TX, US
Michael Fountain - Houston TX, US
Preethi Gunaratne - Houston TX, US
Matthew A. Anderson - Houston TX, US
Chad Creighton - Houston TX, US
Zhifeng Yu - Houston TX, US
Michael Fountain - Houston TX, US
Preethi Gunaratne - Houston TX, US
Matthew A. Anderson - Houston TX, US
Assignee:
Baylor College of Medicine - Houston TX
International Classification:
A61K 31/7088, A61P 35/00
US Classification:
514 44 R
Abstract:
The present invention generally concerns methods and compositions for treating and/or preventing cancer with microRNAs. In specific embodiments, the present invention encompasses a particular microRNA, microRNA-31, as useful in cancer therapy and/or prevention. Specific cancers may be treated, including at least ovarian, prostate, urothelial, osteosarcoma, and glioblastoma.
Tex14 Peptides As Novel Antitumor Agents
US Patent:
2013022, Aug 29, 2013
Filed:
Sep 30, 2010
Appl. No.:
13/499401
Inventors:
Martin M. Matzuk - Houston TX, US
Tokuko Iwamori - Houston TX, US
Michael P. Greenbaum - Nashville TN, US
Lang Ma - Houston TX, US
Naoki Iwamori - Houston TX, US
Tokuko Iwamori - Houston TX, US
Michael P. Greenbaum - Nashville TN, US
Lang Ma - Houston TX, US
Naoki Iwamori - Houston TX, US
Assignee:
Baylor Licnensing Group - Houston TX
International Classification:
C07K 14/47, A61K 38/17, A61K 45/06
US Classification:
514 194, 530329, 530350, 514 193, 514 195, 435375, 600 1
Abstract:
Embodiments of the present invention regard TEX14 peptides for cancer treatment. In particular, the TEX14 peptides comprise a GPPX3Y motif. Methods, compositions, and kits are encompassed.
Male Contraceptive Compositions And Methods Of Use
US Patent:
2013021, Aug 15, 2013
Filed:
May 16, 2011
Appl. No.:
13/698006
Inventors:
James Elliott Bradner - Weston MA, US
Martin Matzuk - Houston TX, US
Jun Qi - Sharon MA, US
Martin Matzuk - Houston TX, US
Jun Qi - Sharon MA, US
International Classification:
A61K 31/551
US Classification:
514220
Abstract:
The invention relates to compositions and methods for effecting male contraception.